We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Scientists Create Artificial Antibiotics

By Biotechdaily staff writers
Posted on 24 May 2002
Scientists have synthesized acrylamide polymer molecules that exhibit the amphiphilic structure of cell membranes and behave like antibiotics. More...
The research was reported in a special section on supramolecular chemistry in the April 16, 2002, issue of the Proceedings of the National Academy of Sciences.

"These custom-built molecules can mimic the complex structures and remarkable biological properties of proteins that fight bacteria,” said Gregory Tew of the University of Massachusetts (Amherst, USA). "The potential ability to keep surfaces and materials permanently antiseptic has significant implications and is very exciting.”

The objective of the project was to synthesize molecules that would mimic the defensive peptides that circulate in the blood and act against invading pathogens even before white blood cells begin to function. There are more than 500 of these natural, bacteria-fighting peptides known. They act by disrupting the bacterial cell membrane. This happens because the negatively charged bacteria physically attract the positively charged peptides. The newly designed synthetic molecules are attracted in the same fashion. Then, once the polymer has bound to the bacterial cell membrane, its amphiphilic properties cause holes to form that allow the cell contents to leak out and result in the death of the organism.

What is novel in the current study is that the researchers focused on the overall shape of the peptides, rather than the specific chemistry. Tew explained, "The antimicrobial activity of this class of peptides depends on its overall physiochemical properties, rather than the precise details of its amino acids.”



Related Links:
University of Massachusetts

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.